Australia, July 22 -- PARABILIS MEDICINES Inc., owns the trademark (2544225) for 'PARABILIS MEDICINES' till March 6, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; pharmaceutical preparations; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions.] and 42 [Drug discovery services; scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals.]
Type of Mark: Word
Date of Acceptance: May 14
Registration Advertised: July 21
For further details contact Steven A. Abreu Sunstein LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2544225.
Disclaimer: Curated by HT Syndication.
